{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:24:59Z","timestamp":1740108299701,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T00:00:00Z","timestamp":1684454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Medical Research Center of Endocrine Diseases of Gansu Province","award":["No. 20JR10FA667"],"award-info":[{"award-number":["No. 20JR10FA667"]}]},{"name":"Science and Technology Planning project of Lanzhou Chengguan District","award":["No. 2021JSCX0011"],"award-info":[{"award-number":["No. 2021JSCX0011"]}]},{"DOI":"10.13039\/501100004775","name":"Natural Science Foundation of Gansu Province","doi-asserted-by":"crossref","award":["No. 21JR1RA080"],"award-info":[{"award-number":["No. 21JR1RA080"]}],"id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00198-023-06785-9","type":"journal-article","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T08:01:53Z","timestamp":1684483313000},"page":"1465-1476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of C-peptide level with bone mineral density in type 2 diabetes mellitus"],"prefix":"10.1007","volume":"34","author":[{"given":"Hong","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3059-6549","authenticated-orcid":false,"given":"Haihong","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songbo","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,19]]},"reference":[{"key":"6785_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mcna.2014.08.015","volume":"99","author":"CC Thomas","year":"2015","unstructured":"Thomas CC, Philipson LH (2015) Update on diabetes classification. Med Clin North Am 99:1\u201316. https:\/\/doi.org\/10.1016\/j.mcna.2014.08.015","journal-title":"Med Clin North Am"},{"key":"6785_CR2","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98:2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"6785_CR3","unstructured":"Venugopal SK, Mowery ML, Jialal I (2022) C Peptide. StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC. https:\/\/pubmed.ncbi.nlm.nih.gov\/30252282\/. Accessed 24 Mar 2022"},{"key":"6785_CR4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","volume":"8","author":"E Leighton","year":"2017","unstructured":"Leighton E, Sainsbury CA, Jones GC (2017) A practical review of C-peptide testing in diabetes. Diabetes Ther 8:475\u2013487. https:\/\/doi.org\/10.1007\/s13300-017-0265-4","journal-title":"Diabetes Ther"},{"key":"6785_CR5","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dme.12159","volume":"30","author":"AG Jones","year":"2013","unstructured":"Jones AG, Hattersley AT (2013) The clinical utility of C-peptide measurement in the care of patients with diabetes. Diabet Med 30:803\u2013817. https:\/\/doi.org\/10.1111\/dme.12159","journal-title":"Diabet Med"},{"key":"6785_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2265.1985.tb00185.x","volume":"23","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Rudenski AS, Burnett MA, Darling P, Turner RC (1985) The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. Clin Endocrinol 23:71\u201379. https:\/\/doi.org\/10.1111\/j.1365-2265.1985.tb00185.x","journal-title":"Clin Endocrinol"},{"key":"6785_CR7","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0026-0495(86)90111-3","volume":"35","author":"BJ Hoogwerf","year":"1986","unstructured":"Hoogwerf BJ, Bantle JP, Gaenslen HE, Greenberg BZ, Senske BJ, Francis R, Goetz FC (1986) Infusion of synthetic human C-peptide does not affect plasma glucose, serum insulin, or plasma glucagon in healthy subjects. Metab Clin Exp 35:122\u2013125. https:\/\/doi.org\/10.1016\/0026-0495(86)90111-3","journal-title":"Metab Clin Exp"},{"key":"6785_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1172\/jci106317","volume":"49","author":"AE Kitabchi","year":"1970","unstructured":"Kitabchi AE (1970) The biological and immunological properties of pork and beef insulin, proinsulin, and connecting peptides. J Clin Investig 49:979\u2013987. https:\/\/doi.org\/10.1172\/jci106317","journal-title":"J Clin Investig"},{"key":"6785_CR9","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/bf00402543","volume":"35","author":"BL Johansson","year":"1992","unstructured":"Johansson BL, Sj\u00f6berg S, Wahren J (1992) The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35:121\u2013128. https:\/\/doi.org\/10.1007\/bf00402543","journal-title":"Diabetologia"},{"key":"6785_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13098-017-0208-2","volume":"9","author":"X Qiao","year":"2017","unstructured":"Qiao X, Zheng H, Zhang S et al (2017) C-peptide is independent associated with diabetic peripheral neuropathy: a community-based study. Diabetol Metab Syndr 9:12. https:\/\/doi.org\/10.1186\/s13098-017-0208-2","journal-title":"Diabetol Metab Syndr"},{"key":"6785_CR11","doi-asserted-by":"publisher","first-page":"e0127112","DOI":"10.1371\/journal.pone.0127112","volume":"10","author":"L Wang","year":"2015","unstructured":"Wang L, Lin P, Ma A et al (2015) C-peptide is independently associated with an increased risk of coronary artery disease in T2DM subjects: a cross-sectional study. PLoS One 10:e0127112. https:\/\/doi.org\/10.1371\/journal.pone.0127112","journal-title":"PLoS One"},{"key":"6785_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2337\/dc08-1241","volume":"32","author":"F Panero","year":"2009","unstructured":"Panero F, Novelli G, Zucco C, Fornengo P, Perotto M, Segre O, Grassi G, Cavallo-Perin P, Bruno G (2009) Fasting plasma C-peptide and micro- and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients. Diabetes Care 32:301\u2013305. https:\/\/doi.org\/10.2337\/dc08-1241","journal-title":"Diabetes Care"},{"key":"6785_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00223-020-00716-0","volume":"107","author":"S Maurotti","year":"2020","unstructured":"Maurotti S, Russo C, Musolino V et al (2020) Effects of C-peptide replacement therapy on bone microarchitecture parameters in streptozotocin-diabetic rats. Calcif Tissue Int 107:266\u2013280. https:\/\/doi.org\/10.1007\/s00223-020-00716-0","journal-title":"Calcif Tissue Int"},{"key":"6785_CR14","doi-asserted-by":"publisher","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK Jr, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289:E735-745. https:\/\/doi.org\/10.1152\/ajpendo.00159.2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6785_CR15","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1055\/s-0033-1347208","volume":"45","author":"M Landreh","year":"2013","unstructured":"Landreh M, Johansson J, J\u00f6rnvall H (2013) C-peptide: a molecule balancing insulin states in secretion and diabetes-associated depository conditions. Horm Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme 45:769\u2013773. https:\/\/doi.org\/10.1055\/s-0033-1347208","journal-title":"Horm Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"6785_CR16","doi-asserted-by":"publisher","first-page":"170557","DOI":"10.1016\/j.peptides.2021.170557","volume":"142","author":"J Luo","year":"2021","unstructured":"Luo J, Jiang J, Huang H, Jiang F, Xu Z, Zhou Z, Zhu H (2021) C-peptide ameliorates high glucose-induced podocyte dysfunction through the regulation of the Notch and TGF-\u03b2 signaling pathways. Peptides 142:170557. https:\/\/doi.org\/10.1016\/j.peptides.2021.170557","journal-title":"Peptides"},{"key":"6785_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/jbmr.3871","volume":"35","author":"J Xu","year":"2020","unstructured":"Xu J, Liu J, Gan Y, Dai K, Zhao J, Huang M, Huang Y, Zhuang Y, Zhang X (2020) High-dose TGF-\u03b21 impairs mesenchymal stem cell-mediated bone regeneration via Bmp2 inhibition. J Bone Miner Res Off J Am Soc Bone Miner Res 35:167\u2013180. https:\/\/doi.org\/10.1002\/jbmr.3871","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6785_CR18","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s40618-017-0672-4","volume":"40","author":"Y Ferro","year":"2017","unstructured":"Ferro Y, Russo C, Russo D et al (2017) Association between low C-peptide and fragility fractures in postmenopausal women without diabetes. J Endocrinol Invest 40:1091\u20131098. https:\/\/doi.org\/10.1007\/s40618-017-0672-4","journal-title":"J Endocrinol Invest"},{"key":"6785_CR19","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s40618-020-01472-6","volume":"44","author":"M Zhang","year":"2021","unstructured":"Zhang M, Sheng C, You H, Cai M, Gao J, Cheng X, Sheng H, Qu S (2021) Comparing the bone mineral density among male patients with latent autoimmune diabetes and classical type 1 and type 2 diabetes, and exploring risk factors for osteoporosis. J Endocrinol Invest 44:1659\u20131665. https:\/\/doi.org\/10.1007\/s40618-020-01472-6","journal-title":"J Endocrinol Invest"},{"key":"6785_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00223-009-9272-4","volume":"85","author":"I Kanazawa","year":"2009","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2009) Serum osteocalcin\/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes. Calcif Tissue Int 85:228\u2013234. https:\/\/doi.org\/10.1007\/s00223-009-9272-4","journal-title":"Calcif Tissue Int"},{"key":"6785_CR21","doi-asserted-by":"publisher","unstructured":"Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2007) Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 18:1675-1681.https:\/\/doi.org\/10.1007\/s00198-007-0430-0","DOI":"10.1007\/s00198-007-0430-0"},{"key":"6785_CR22","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1359\/jbmr.081207","volume":"24","author":"M Yamamoto","year":"2009","unstructured":"Yamamoto M, Yamaguchi T, Yamauchi M, Kaji H, Sugimoto T (2009) Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications. J Bone Miner Res Off J Am Soc Bone Miner Res 24:702\u2013709. https:\/\/doi.org\/10.1359\/jbmr.081207","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6785_CR23","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Od\u00e9n A, Leslie WD, McCloskey EV (2017) FRAX update. J Clin Densitom Off J Int Soc Clin Densitom 20:360\u2013367. https:\/\/doi.org\/10.1016\/j.jocd.2017.06.022","journal-title":"J Clin Densitom Off J Int Soc Clin Densitom"},{"key":"6785_CR24","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/1753-0407.12962","volume":"11","author":"JM Liu","year":"2019","unstructured":"Liu JM, Zhu DL, Mu YM, Xia WB (2019) Management of fracture risk in patients with diabetes-Chinese Expert Consensus. J Diabetes 11:906\u2013919. https:\/\/doi.org\/10.1111\/1753-0407.12962","journal-title":"J Diabetes"},{"key":"6785_CR25","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/jbmr.3538","volume":"33","author":"WD Leslie","year":"2018","unstructured":"Leslie WD, Johansson H, McCloskey EV, Harvey NC, Kanis JA, Hans D (2018) Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD registry. J Bone Miner Res Off J Am Soc Bone Miner Res 33:1923\u20131930. https:\/\/doi.org\/10.1002\/jbmr.3538","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"6785_CR26","doi-asserted-by":"publisher","unstructured":"Lv F, Cai X, Zhang R, Zhou L, Zhou X, Han X, Ji L (2021) Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes. Osteoporos Int : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32:1165-1173.https:\/\/doi.org\/10.1007\/s00198-020-05790-6","DOI":"10.1007\/s00198-020-05790-6"},{"key":"6785_CR27","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s12020-021-02724-y","volume":"73","author":"Z Wen","year":"2021","unstructured":"Wen Z, Ding N, Chen R, Liu S, Wang Q, Sheng Z, Liu H (2021) Comparison of methods to improve fracture risk assessment in chinese diabetic postmenopausal women: a case-control study. Endocrine 73:209\u2013216. https:\/\/doi.org\/10.1007\/s12020-021-02724-y","journal-title":"Endocrine"},{"key":"6785_CR28","doi-asserted-by":"publisher","first-page":"3621","DOI":"10.1210\/jc.2017-00042","volume":"102","author":"SA Paschou","year":"2017","unstructured":"Paschou SA, Dede AD, Anagnostis PG, Vryonidou A, Morganstein D, Goulis DG (2017) Type 2 diabetes and osteoporosis: a guide to optimal management. J Clin Endocrinol Metab 102:3621\u20133634. https:\/\/doi.org\/10.1210\/jc.2017-00042","journal-title":"J Clin Endocrinol Metab"},{"key":"6785_CR29","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.mce.2016.12.012","volume":"442","author":"C Russo","year":"2017","unstructured":"Russo C, Lazzaro V, Gazzaruso C et al (2017) Proinsulin C-peptide modulates the expression of ERK1\/2, type I collagen and RANKL in human osteoblast-like cells (Saos-2). Mol Cell Endocrinol 442:134\u2013141. https:\/\/doi.org\/10.1016\/j.mce.2016.12.012","journal-title":"Mol Cell Endocrinol"},{"key":"6785_CR30","doi-asserted-by":"publisher","first-page":"e28294","DOI":"10.1371\/journal.pone.0028294","volume":"6","author":"D Galuska","year":"2011","unstructured":"Galuska D, Pirkmajer S, Barr\u00e8s R, Ekberg K, Wahren J, Chibalin AV (2011) C-peptide increases Na, K-ATPase expression via PKC- and MAP kinase-dependent activation of transcription factor ZEB in human renal tubular cells. PLoS One 6:e28294. https:\/\/doi.org\/10.1371\/journal.pone.0028294","journal-title":"PLoS One"},{"key":"6785_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/dmrr.1071","volume":"26","author":"L Nordquist","year":"2010","unstructured":"Nordquist L, Shimada K, Ishii T, Furuya DT, Kamikawa A, Kimura K (2010) Proinsulin C-peptide prevents type-1 diabetes-induced decrease of renal Na+-K+-ATPase alpha1-subunit in rats. Diabetes Metab Res Rev 26:193\u2013199. https:\/\/doi.org\/10.1002\/dmrr.1071","journal-title":"Diabetes Metab Res Rev"},{"key":"6785_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/bf02555151","volume":"43","author":"J Caverzasio","year":"1988","unstructured":"Caverzasio J, Selz T, Bonjour JP (1988) Characteristics of phosphate transport in osteoblastlike cells. Calcif Tissue Int 43:83\u201387. https:\/\/doi.org\/10.1007\/bf02555151","journal-title":"Calcif Tissue Int"},{"key":"6785_CR33","doi-asserted-by":"publisher","first-page":"708384","DOI":"10.3389\/fcell.2021.708384","volume":"9","author":"M Marchini","year":"2021","unstructured":"Marchini M, Ashkin MR, Bellini M, Sun MM, Workentine ML, Okuyan HM, Krawetz R, Beier F, Rolian C (2021) A Na(+)\/K(+) ATPase pump regulates chondrocyte differentiation and bone length variation in mice. Front Cell Dev Biol 9:708384. https:\/\/doi.org\/10.3389\/fcell.2021.708384","journal-title":"Front Cell Dev Biol"},{"key":"6785_CR34","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.actbio.2021.05.026","volume":"129","author":"Z Tang","year":"2021","unstructured":"Tang Z, Chen S, Ni Y, Zhao R, Zhu X, Yang X, Zhang X (2021) Role of Na(+), K(+)-ATPase ion pump in osteoinduction. Acta Biomater 129:293\u2013308. https:\/\/doi.org\/10.1016\/j.actbio.2021.05.026","journal-title":"Acta Biomater"},{"key":"6785_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.bcp.2018.08.024","volume":"156","author":"S Xiong","year":"2018","unstructured":"Xiong S, Yang X, Yan X, Hua F, Zhu M, Guo L, Wu Z, Bian JS (2018) Immunization with Na(+)\/K(+) ATPase DR peptide prevents bone loss in an ovariectomized rat osteoporosis model. Biochem Pharmacol 156:281\u2013290. https:\/\/doi.org\/10.1016\/j.bcp.2018.08.024","journal-title":"Biochem Pharmacol"},{"key":"6785_CR36","doi-asserted-by":"publisher","first-page":"e3390","DOI":"10.1002\/dmrr.3390","volume":"37","author":"Y Hu","year":"2021","unstructured":"Hu Y, Li X, Yan X, Huang G, Dai R, Zhou Z (2021) Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes. Diabetes Metab Res Rev 37:e3390. https:\/\/doi.org\/10.1002\/dmrr.3390","journal-title":"Diabetes Metab Res Rev"},{"key":"6785_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.4158\/ep.7.5.346","volume":"7","author":"PJ L\u00f3pez-Ibarra","year":"2001","unstructured":"L\u00f3pez-Ibarra PJ, Pastor MM, Escobar-Jim\u00e9nez F, Pardo MD, Gonz\u00e1lez AG, Luna JD, Requena ME, Diosdado MA (2001) Bone mineral density at time of clinical diagnosis of adult-onset type 1 diabetes mellitus. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists 7:346\u2013351. https:\/\/doi.org\/10.4158\/ep.7.5.346","journal-title":"Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinologists"},{"key":"6785_CR38","doi-asserted-by":"publisher","first-page":"13318","DOI":"10.1073\/pnas.96.23.13318","volume":"96","author":"R Rigler","year":"1999","unstructured":"Rigler R, Pramanik A, Jonasson P et al (1999) Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 96:13318\u201313323. https:\/\/doi.org\/10.1073\/pnas.96.23.13318","journal-title":"Proc Natl Acad Sci USA"},{"key":"6785_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1006\/bbrc.2000.4135","volume":"280","author":"M Henriksson","year":"2001","unstructured":"Henriksson M, Pramanik A, Shafqat J, Zhong Z, Tally M, Ekberg K, Wahren J, Rigler R, Johansson J, J\u00f6rnvall H (2001) Specific binding of proinsulin C-peptide to intact and to detergent-solubilized human skin fibroblasts. Biochem Biophys Res Commun 280:423\u2013427. https:\/\/doi.org\/10.1006\/bbrc.2000.4135","journal-title":"Biochem Biophys Res Commun"},{"key":"6785_CR40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1006\/bbrc.2001.4917","volume":"284","author":"A Pramanik","year":"2001","unstructured":"Pramanik A, Ekberg K, Zhong Z et al (2001) C-peptide binding to human cell membranes: importance of Glu27. Biochem Biophys Res Commun 284:94\u201398. https:\/\/doi.org\/10.1006\/bbrc.2001.4917","journal-title":"Biochem Biophys Res Commun"},{"key":"6785_CR41","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.bone.2009.05.003","volume":"45","author":"T Yamaguchi","year":"2009","unstructured":"Yamaguchi T, Kanazawa I, Yamamoto M, Kurioka S, Yamauchi M, Yano S, Sugimoto T (2009) Associations between components of the metabolic syndrome versus bone mineral density and vertebral fractures in patients with type 2 diabetes. Bone 45:174\u2013179. https:\/\/doi.org\/10.1016\/j.bone.2009.05.003","journal-title":"Bone"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06785-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06785-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T05:03:24Z","timestamp":1690520604000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06785-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,19]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["6785"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06785-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2023,5,19]]},"assertion":[{"value":"22 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}